Lab VerifiedGLP-1 / GIP dual agonist
Tirzepatide
40mg · prefilled pen
A dual GLP-1 / GIP receptor agonist used within physician-directed metabolic programs.
What this involves
Complete a short assessment. A licensed provider reviews your information and determines whether this product is appropriate — nothing is dispensed without that review.
Research Context
Tirzepatide acts on both GLP-1 and GIP receptors. Prescription-only; a licensed provider determines suitability, dosing, and titration through the assessment.
Detailed monographs, dosing references, and per-batch Certificates of Analysis are provided through your provider and our verification library.
Why USA Direct Rx
- Licensed US prescriber review
- US pharmacy dispensed
- Lab-verified purity per batch
- Real card payments — no crypto or cash-app
- Discreet, tracked shipping
Commonly Paired
Semaglutide
View
Compliance & Legal Status
Products are dispensed only pursuant to a valid prescription issued by a licensed provider after review of your assessment. Submitting an assessment is not a guarantee of prescription. Nothing on this page is medical advice or a claim to diagnose, treat, cure, or prevent any disease.
